South Korea to Sharply Increase R&D Support for New Drugs in 2008 (South Korea)
This article was originally published in PharmAsia News
In an attempt to expand its reach in the global pharmaceutical market, South Korea has announced it will significantly increase financial support for drug discovery and development. In 2008, the Ministry of Science and Technology will boost the country's research and development budget by 52 percent to $100.3 million. The government hopes by pouring this amount of money into pharmaceuticals, South Korea will be able to produce one new drug every year until 2016. (Click here for more - May Require Paid Subscription
You may also be interested in...
Teligent has achieved a “pivotal step in our journey toward securing a strong financial future,” according to management, after recapitalizing its significant debt burden and gaining access to more cash.
Pfizer has entered into an agreement with Premier to supply five essential medications to US healthcare providers through Premier’s ProvideGx program. Both companies aim to secure supply of products specifically used by COVID patients.
Announcing his “first step to take on pricing of generic drugs,” billionaire Mark Cuban recently associated his name with a new US generics company “to show that capitalism can be compassionate.” In an exclusive chat with Generics Bulletin, the newly established company’s CEO Alex Oshmyansky revealed that they started working on the company “in stealth” since 2018.